A team of scientists are working to develop treatment using full body transplant and some believe that such treatment might be ready in two years.
Dr Sergio Canavero, the Italian neurosurgeon has proposed carrying out a new the first fullbody transplant. Dr Canavero has said that he is aware of ethical and philosophical issues posed by such an operation. Dr Canavero had proposed in 2013 that after two years, he would be able to perform the first human head transplant.
"The 'chimera' would carry the mind of the recipient but, should he or she reproduce, the offspring would carry the genetic inheritance of the donor," Dr Canavero had said in 2013. Dr Canavero has said that it will take two more years of research before the first full body transplant is performed.
However, a number of neurosurgeons have serious doubts over the possibility of the surgery so soon. Connecting blood vessels and tissues might be achieved but the problem would be in fusing of one spinal cord to another so that the brain can communicate with the rest of the body.
"This is of course totally different from what happens in clinical spinal cord injury, where gross damage and scarring hinder regeneration. This 'clean cut' is the key to spinal cord fusion," Dr Canavero says.
In a recently published blog post, "social media theorist" and Snapchat researcher Nathan Jurgenson has revealed that Snapchat is funding a new online magazine called 'Real Life.'
In announcing that Snapchat is bankrolling the new 'Real...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an apparent attempt to enhance the visual experience for Google search users carrying out...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In a recently published blog post, "social media...
With tech giant Google scheduled to launch the Play...
Monohm Inc.’s incredibly weird circular smartphone-cum-...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).